Healthcare investment firm CBC has partnered with APG Asset Management to offer a new Asia-Pacific healthcare platform called CBC Healthcare Infrastructure Platform, as well as a China-focused life sciences venture fund named CBC China Life Science Infrastructure Venture.
The CBC China Life Science Infrastructure Venture fund held its first close of $500 million and has a hard cap of $1.5 billion. The fund will invest in facilities for life science research, manufacturing and support services for biotech incubators all the way through to large multinational pharmaceutical companies in China.
The CBC Healthcare . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available. Research articles require an Annual sub.